Cargando…
Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A tota...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719925/ https://www.ncbi.nlm.nih.gov/pubmed/35272846 http://dx.doi.org/10.1016/j.fertnstert.2021.12.032 |
_version_ | 1784625040402153472 |
---|---|
author | Boudry, Liese Essahib, Wafaa Mateizel, Ileana Van de Velde, Hilde De Geyter, Deborah Piérard, Denis Waelput, Wim Uvin, Valerie Tournaye, Herman De Vos, Michel De Brucker, Michael |
author_facet | Boudry, Liese Essahib, Wafaa Mateizel, Ileana Van de Velde, Hilde De Geyter, Deborah Piérard, Denis Waelput, Wim Uvin, Valerie Tournaye, Herman De Vos, Michel De Brucker, Michael |
author_sort | Boudry, Liese |
collection | PubMed |
description | OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A total of 16 patients undergoing transvaginal oocyte retrieval who had a positive SARS-CoV-2 RNA test <48 hours before the procedure. All patients underwent the retrieval between September 2020 and June 2021 and used in vitro fertilization or intracytoplasmic sperm injection. All embryos were vitrified to avoid conception during SARS-CoV-2 infection. INTERVENTION(S): Follicular fluid aspirated during oocyte retrieval, cumulus cells, and endometrial samples were analyzed for SARS-CoV-2 RNA using the RealStar SARS-CoV-2 RT-PCR-Kit1.0. MAIN OUTCOME MEASURE(S): The primary outcome parameter was the detection of viral RNA in the follicular fluid, cumulus cells, and endometrial cells. Fertilization rate, embryo developmental potential, and clinical outcome after frozen embryo transfer were secondary outcome parameters. RESULT(S): Samples from 16 patients were analyzed. Cycle threshold values of <40 were considered positive. All samples were negative for SARS-CoV-2 viral RNA. No inflammatory lesions of the endometrium were identified histologically. Fertilization rate, embryo development, and clinical outcomes after embryo transfer were reassuring. CONCLUSION(S): In women infected with SARS-CoV-2 who underwent ART, viral RNA was undetectable in the follicular fluid, cumulus cells, and endometrium. Caution is warranted in view of the small sample size, and the risk of SARS-CoV-2 affecting the embryo via ART cannot be ruled out. Adequate counseling of women and couples undergoing ART is crucial in parallel with further research on the effect of exposure of the early human embryo to SARS-CoV-2. CLINICAL TRIAL REGISTRATION NUMBER: NCT04425317. |
format | Online Article Text |
id | pubmed-8719925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-87199252022-01-03 Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women Boudry, Liese Essahib, Wafaa Mateizel, Ileana Van de Velde, Hilde De Geyter, Deborah Piérard, Denis Waelput, Wim Uvin, Valerie Tournaye, Herman De Vos, Michel De Brucker, Michael Fertil Steril Original Article OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A total of 16 patients undergoing transvaginal oocyte retrieval who had a positive SARS-CoV-2 RNA test <48 hours before the procedure. All patients underwent the retrieval between September 2020 and June 2021 and used in vitro fertilization or intracytoplasmic sperm injection. All embryos were vitrified to avoid conception during SARS-CoV-2 infection. INTERVENTION(S): Follicular fluid aspirated during oocyte retrieval, cumulus cells, and endometrial samples were analyzed for SARS-CoV-2 RNA using the RealStar SARS-CoV-2 RT-PCR-Kit1.0. MAIN OUTCOME MEASURE(S): The primary outcome parameter was the detection of viral RNA in the follicular fluid, cumulus cells, and endometrial cells. Fertilization rate, embryo developmental potential, and clinical outcome after frozen embryo transfer were secondary outcome parameters. RESULT(S): Samples from 16 patients were analyzed. Cycle threshold values of <40 were considered positive. All samples were negative for SARS-CoV-2 viral RNA. No inflammatory lesions of the endometrium were identified histologically. Fertilization rate, embryo development, and clinical outcomes after embryo transfer were reassuring. CONCLUSION(S): In women infected with SARS-CoV-2 who underwent ART, viral RNA was undetectable in the follicular fluid, cumulus cells, and endometrium. Caution is warranted in view of the small sample size, and the risk of SARS-CoV-2 affecting the embryo via ART cannot be ruled out. Adequate counseling of women and couples undergoing ART is crucial in parallel with further research on the effect of exposure of the early human embryo to SARS-CoV-2. CLINICAL TRIAL REGISTRATION NUMBER: NCT04425317. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine 2022-04 2022-01-01 /pmc/articles/PMC8719925/ /pubmed/35272846 http://dx.doi.org/10.1016/j.fertnstert.2021.12.032 Text en ©2022 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Boudry, Liese Essahib, Wafaa Mateizel, Ileana Van de Velde, Hilde De Geyter, Deborah Piérard, Denis Waelput, Wim Uvin, Valerie Tournaye, Herman De Vos, Michel De Brucker, Michael Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title | Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title_full | Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title_fullStr | Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title_full_unstemmed | Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title_short | Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women |
title_sort | undetectable viral rna in follicular fluid, cumulus cells, and endometrial tissue samples in sars-cov-2–positive women |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719925/ https://www.ncbi.nlm.nih.gov/pubmed/35272846 http://dx.doi.org/10.1016/j.fertnstert.2021.12.032 |
work_keys_str_mv | AT boudryliese undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT essahibwafaa undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT mateizelileana undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT vandeveldehilde undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT degeyterdeborah undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT pierarddenis undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT waelputwim undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT uvinvalerie undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT tournayeherman undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT devosmichel undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen AT debruckermichael undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen |